Back
EBCL-0009
Angiogenesis is the essential physiological process of the formation of new blood vessels from existing ones, formed earlier at the stage of vasculogenesis. It is a crucial process for the growth and development of the human body, as well as for wound healing by the formation of granulation tissue. Disorders in the angiogenesis-related signaling pathways lead to cancer or cardiovascular diseases. These diseases can be controlled by exogenous angiogenesis activators (cardiovascular) or inhibitors (cancer). Some key activators of angiogenesis include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), angiogenin, TGF-β, etc. The angiogenesis inhibitors are angiostatin, endostatin, interferon, platelet factor 4, etc.
Angiogenesis Related Ligands Library consists of 677 small ligands, some representative molecules are given below: TSC359, FLT3 inhibitor; ML106, DYRK1A inhibitor; DB04760, Collagenase 3 inhibitor; Fedratinib, Cyclin-G-associated kinase inhibitor.
Related terms: COX-1 , COX-2, epidermal growth factor, fms related receptor tyrosine kinase, platelet derived growth factor, fibroblast growth factor, AT1 receptor, MMP8
Representation of the connection between angiogenesis and cancer tumor growth (Created By BioRender.com)
We propose the complete list of Services powered by Enamine
All our products are for research purpose only. Any personal or non-scientific use is strictly prohibited.
NoteAll the compounds with solubility below 10 mM are shipped as 2 mM solutions.
COX-2
32
32
Number of compounds
32
epidermal growth factor receptor
29
29
Number of compounds
29
COX-1
24
24
Number of compounds
24
fms related receptor tyrosine kinase 3
21
21
Number of compounds
21
kinase insert domain receptor
16
16
Number of compounds
16